<DOC>
	<DOCNO>NCT01742091</DOCNO>
	<brief_summary>The purpose study assess safety side effect multiple dos LY2541546 postmenopausal woman give subcutaneously ( injection skin ) intravenously ( directly vein ) . The study also test long take study drug get body , long take body get rid , overall effect study drug body , whether antibody study drug form .</brief_summary>
	<brief_title>A Multiple Dose Study LY2541546 Healthy Postmenopausal Women</brief_title>
	<detailed_description />
	<criteria>Healthy postmenopausal female , determine medical history physical examination Body mass index ( BMI ) screen 19.0 32.0 kilogram per square meter ( kg/m^2 ) , inclusive Acceptable clinical laboratory test result , blood pressure heart rate Have give write informed consent Within 30 day initial dose study drug , receive treatment drug receive regulatory approval indication Have receive study treatment trial investigational osteoporosis treatment , include LY2561553 ( parathyroid hormone receptor modulator ) , within 12 week screen 5 halflives , whichever long Known allergy LY2541546 , constituent , related compound Persons previously participate study study LY2541546 History presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder History presence low platelet count , bleed issue family history bleed disorder Paget 's disease , parathyroid disease , thyroid disease Fracture long bone within 12 week screen Regular use know drug abuse and/or positive finding urinary drug screen Evidence human immunodeficiency virus ( HIV ) , hepatitis C , hepatitis B and/or positive antiHIV antibody , hepatitis C antibody , hepatitis B surface antigen Current use therapy osteoporosis use hormone replacement therapy ( HRT ) within previous 12 month Blood donation within last month Are unwilling unable maintain normal pattern alcohol , caffeine , smoking , exercise start end study abide clinical research unit restriction . Note : Average weekly alcohol intake must exceed 14 unit per week Are unable unwilling refrain nicotine usage Clinical Research Unit ( CRU ) confinement</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Postmenopausal female</keyword>
	<keyword>Volunteers</keyword>
</DOC>